Integra LifeSciences Reports 2Q19 Orthopedic Revenue of $21.8MM, -1.2% vs. 2Q18


New product introductions and a dedicated orthopedics sales channel have Integra LifeSciences positioned for mid-single digit growth in the second half of 2019.

Orthopedic sales impacted by case scheduling delays in high volume accounts.
While still negative, sales of lower extremity fixation products increased sequentially...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us